(ENX) Euronext - Ratings and Ratios
Securities Trading, Derivatives Trading, Market Data, Listing Services, Post-Trade
Dividends
| Dividend Yield | 2.19% |
| Yield on Cost 5y | 4.04% |
| Yield CAGR 5y | 11.75% |
| Payout Consistency | 97.5% |
| Payout Ratio | 45.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 17.9% |
| Value at Risk 5%th | 28.1% |
| Relative Tail Risk | -4.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.19 |
| Alpha | 23.74 |
| CAGR/Max DD | 1.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.573 |
| Beta | 0.030 |
| Beta Downside | 0.038 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.42% |
| Mean DD | 5.55% |
| Median DD | 2.42% |
Description: ENX Euronext October 30, 2025
Euronext N.V. (ENX) operates a pan-European network of securities and derivatives exchanges-including venues in the Netherlands, France, Italy, Belgium, Portugal, Ireland, Norway, Denmark, and the United States-plus a suite of ancillary services such as market-data distribution, post-trade clearing, custody, and technology solutions for third-party venues.
The core product set includes cash-equities listings, multilateral trading facilities (MTFs) for equities, fixed-income, and exchange-traded products, as well as options on blue-chip stocks and commodity futures (e.g., milling-wheat contracts). Euronext also monetises real-time, historical, and reference data, and offers colocation, network, and regulatory-reporting services to institutional clients.
Key recent metrics (FY 2023): net revenue €1.47 bn (+5 % YoY), trading volume growth of 3 % across cash equities, and a 7 % increase in data-service subscriptions, reflecting continued demand for low-latency market infrastructure and ESG-focused listings.
Sector drivers that materially affect Euronext’s outlook include: (1) the EU’s MiFID II and upcoming MiFID III reforms, which tighten transparency and could boost data-service revenues; (2) the ongoing consolidation of European exchanges, positioning Euronext as a preferred partner for cross-border listings; and (3) macro-economic trends in the eurozone-particularly GDP growth and corporate earnings-since they directly influence trading activity and new-issue pipelines.
Given the company’s diversified revenue streams and exposure to both traditional equity markets and fast-growing data services, a deeper quantitative assessment (e.g., discounted cash-flow model using the latest earnings guidance) is warranted; you may find ValueRay’s analyst tools useful for that next step.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (652.7m TTM) > 0 and > 6% of Revenue (6% = 104.1m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.69% (prev 43.97%; Δ -41.28pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 794.4m > Net Income 652.7m (YES >=105%, WARN >=100%) |
| Net Debt (2.09b) to EBITDA (1.11b) ratio: 1.88 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (102.1m) change vs 12m ago -1.78% (target <= -2.0% for YES) |
| Gross Margin 60.29% (prev 83.38%; Δ -23.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.61% (prev 0.72%; Δ -0.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 336.6 (EBITDA TTM 1.11b / Interest Expense TTM 2.72m) >= 6 (WARN >= 3) |
Altman Z'' 0.05
| (A) 0.00 = (Total Current Assets 350.38b - Total Current Liabilities 350.33b) / Total Assets 357.58b |
| (B) 0.01 = Retained Earnings (Balance) 1.89b / Total Assets 357.58b |
| (C) 0.00 = EBIT TTM 914.6m / Avg Total Assets 286.76b |
| (D) 0.01 = Book Value of Equity 2.24b / Total Liabilities 353.29b |
| Total Rating: 0.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.15
| 1. Piotroski 4.50pt |
| 2. FCF Yield -0.22% |
| 3. FCF Margin 41.50% |
| 4. Debt/Equity 0.72 |
| 5. Debt/Ebitda 1.88 |
| 6. ROIC - WACC (= 4.42)% |
| 7. RoE 15.61% |
| 8. Rev. Trend 67.48% |
| 9. EPS Trend 77.90% |
What is the price of ENX shares?
Over the past week, the price has changed by +2.00%, over one month by +6.69%, over three months by -3.99% and over the past year by +28.54%.
Is ENX a buy, sell or hold?
What are the forecasts/targets for the ENX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 146.9 | 11.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 149.8 | 13.2% |
ENX Fundamental Data Overview November 25, 2025
Market Cap EUR = 13.08b (13.08b EUR * 1.0 EUR.EUR)
P/E Trailing = 20.3155
P/E Forward = 16.3934
P/S = 7.3546
P/B = 3.0416
P/EG = 2.2759
Beta = 0.944
Revenue TTM = 1.74b EUR
EBIT TTM = 914.6m EUR
EBITDA TTM = 1.11b EUR
Long Term Debt = 2.31b EUR (from longTermDebt, last quarter)
Short Term Debt = 624.9m EUR (from shortTermDebt, last quarter)
Debt = 3.01b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.09b EUR (from netDebt column, last quarter)
Enterprise Value = -325.22b EUR (13.08b + Debt 3.01b - CCE 341.30b)
Interest Coverage Ratio = 336.6 (Ebit TTM 914.6m / Interest Expense TTM 2.72m)
FCF Yield = -0.22% (FCF TTM 720.2m / Enterprise Value -325.22b)
FCF Margin = 41.50% (FCF TTM 720.2m / Revenue TTM 1.74b)
Net Margin = 37.61% (Net Income TTM 652.7m / Revenue TTM 1.74b)
Gross Margin = 60.29% ((Revenue TTM 1.74b - Cost of Revenue TTM 689.2m) / Revenue TTM)
Gross Margin QoQ = 87.58% (prev 75.25%)
Tobins Q-Ratio = -0.91 (set to none) (Enterprise Value -325.22b / Total Assets 357.58b)
Interest Expense / Debt = 0.04% (Interest Expense 1.22m / Debt 3.01b)
Taxrate = 25.74% (68.1m / 264.5m)
NOPAT = 679.2m (EBIT 914.6m * (1 - 25.74%))
Current Ratio = 1.00 (Total Current Assets 350.38b / Total Current Liabilities 350.33b)
Debt / Equity = 0.72 (Debt 3.01b / totalStockholderEquity, last quarter 4.15b)
Debt / EBITDA = 1.88 (Net Debt 2.09b / EBITDA 1.11b)
Debt / FCF = 2.90 (Net Debt 2.09b / FCF TTM 720.2m)
Total Stockholder Equity = 4.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.18% (Net Income 652.7m / Total Assets 357.58b)
RoE = 15.61% (Net Income TTM 652.7m / Total Stockholder Equity 4.18b)
RoCE = 14.09% (EBIT 914.6m / Capital Employed (Equity 4.18b + L.T.Debt 2.31b))
RoIC = 9.41% (NOPAT 679.2m / Invested Capital 7.22b)
WACC = 4.99% (E(13.08b)/V(16.09b) * Re(6.13%) + D(3.01b)/V(16.09b) * Rd(0.04%) * (1-Tc(0.26)))
Discount Rate = 6.13% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.02%
[DCF Debug] Terminal Value 77.08% ; FCFE base≈476.7m ; Y1≈440.6m ; Y5≈399.4m
Fair Price DCF = 70.67 (DCF Value 7.18b / Shares Outstanding 101.5m; 5y FCF grow -9.54% → 3.0% )
EPS Correlation: 77.90 | EPS CAGR: 6.39% | SUE: 0.0 | # QB: 0
Revenue Correlation: 67.48 | Revenue CAGR: 7.86% | SUE: 1.40 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.92 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=3
EPS current Year (2025-12-31): EPS=7.23 | Chg30d=-0.027 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+11.8%
EPS next Year (2026-12-31): EPS=7.72 | Chg30d=+0.095 | Revisions Net=-2 | Growth EPS=+6.7% | Growth Revenue=+4.9%